A study on pathogenesis of idiopathic interstitial pneumonia : Using ep mice, a mouse model of Hermansky-pudlak syndrome.
A study on pathogenesis of idiopathic interstitial pneumonia : Using ep mice, a mouse model of Hermansky-pudlak syndrome.
批准号:
14570197
负责人:
NAKATANI Yukio
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We recently reported the constant presence of characteristic foamy swelling/degeneration (giant lamellar body degeneration ; GLBD) of type II pneumocytes in the lungs affected by Hermansky-Pudlak syndrome (HPS)-associated interstitial pneumonia (HPSIP), proposing the hypothesis that GLBD may be the triggering factor in the development of HPSIP (Virchows Arch, 2000). We now investigated the lung pathology of pale ear (ep) mouse, a mouse model of HPS1, and of beige (bg) mouse, a mouse model of Chediak-Higashi syndrome (CHS) with a special reference to GLBD and associated pathologic changes. GLBD was found both in ep and bg mice soon after birth, increasingin severity as mice grew older. Younger mice showed only GLBD with no evidence of interstitial change. Aged bg mice (22-24 months) showed the most prominent GLBD, 3 of the 8 cases showing associated lymphocytic infiltration and slight fibrosis of the collapsed alveolar septa as well as intraalveolar macrophage infiltration. Aged ep mice (24 months) with less severe GLBD than that of bg mice of comparative ages also showed a slight tendency to interstitial inflammation but no fibrosis. GLBs in these mice pneumocytes were immunoreactive for surfactant protein B and composed of lamellar structures ultrastructurally, almost identical to human GLBs. The results of the present study supports the hypothesis that GLBD may be playing an important role in the development of HPSIP. Ep and bg mice, especially the latter, may be a useful mouse model of HPSIP.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nakatani, Y et al.: "Hermansky-Pudlak syndrome."Nippon Kyobu Rinsho. 62(11). S210-S219 (2003)
Nakatani, Y 等人:“Hermansky-Pudlak 综合征。”Nippon Kyobu Rinsho。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
中谷行雄, 唐 小燕, 山中 正二, 長嶋洋治, 野沢昭典, 他: "特発性間質性肺炎とその周辺「Hermansky-Pudlak症候群」"日本胸部臨床. 増刊号(発表予定). (2003)
Yukio Nakatani、Xiaoyan Tang、Shoji Yamanaka、Yoji Nagashima、Akinori Nozawa 等:“特发性间质性肺炎及其周围的‘Hermansky-Pudlak 综合征’”日本胸科诊所特刊(即将出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
中谷行雄, 中村宣生, 山中正二, 宮城洋平, 長嶋洋治, 他: "Hermansy-Pudlak症候群"日本胸部臨床. 62. S210-S219 (2003)
Yukio Nakatani、Nobuo Nakamura、Shoji Yamanaka、Yohei Miyagi、Yoji Nagashima 等:“Hermansy-Pudlak 综合征”日本胸科诊所。 62. S210-S219 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
中谷行雄, 中村宣生, 山中 正二, 宮城洋平, 長嶋洋治, 唐 小燕, 他: "特発性間質性肺炎とその周辺「Hennansky-Pudlak症候群」"日本胸部臨床. 62巻11号. S210-S219 (2003)
Yukio Nakatani、Nobuo Nakamura、Shoji Yamanaka、Yohei Miyagi、Yoji Nagashima、Xiaoyan Tang 等:“特发性间质性肺炎及其周围环境‘Hennansky-Pudlak 综合征’”,日本胸部诊所,第 62 卷,第 11 期。 S219 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
MOLECULAR PATHOLOGY ON FOLLICULIN GENE ABNORMALITIES AND TUMORIGENESIS OF VARIOUS ORGANS
-
批准号:15K08374
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2015
-
负责人:NAKATANI Yukio
-
依托单位:
Birt-Hogg-Dube syndrome: Molecular analysis and diagnosis of related lesions
-
批准号:24590408
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:NAKATANI Yukio
-
依托单位:
Role of BHD gene in the development of pulmonary cysts and cancer : A molecular-pathological analysis
-
批准号:21590365
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:NAKATANI Yukio
-
依托单位:
molecular and pathological study on pathogenesis of cystic lung diseases : Analysis of congenital cystic adenomatoid malformation as a model.
-
批准号:17590293
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2005
-
负责人:NAKATANI Yukio
-
依托单位:
Study on pathogenesis of idiopathic interstitial pneumonia : Analysis of Hermansky-Pudlak syndrome as a model.
-
批准号:11670184
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1999
-
负责人:NAKATANI Yukio
-
依托单位:
海外基金